Zura Bio (ZURA) Free Cash Flow (2022 - 2026)

Zura Bio's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$18.9 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 71.09% year-over-year to -$18.9 million in Q1 2026; TTM through Mar 2026 was -$72.8 million, a 108.89% decrease from a year earlier, with the FY2025 full-year figure at -$64.9 million, down 125.65% from the prior year.
• Free Cash Flow advanced to -$18.9 million in Q1 2026 per ZURA's latest filing, from -$22.3 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $391000.0 in Q4 2022 and bottomed at -$22.3 million in Q4 2025.
• The 5-year median for Free Cash Flow is -$5.2 million (2023), against an average of -$7.6 million.
• Across the five-year window, Free Cash Flow sank 1579.55% in 2023 and fell 28.11% in 2024, its largest moves.
• Year by year, Free Cash Flow stood at $391000.0 in 2022, then sank by 1136.57% to -$4.1 million in 2023, then tumbled by 183.54% to -$11.5 million in 2024, then plunged by 94.0% to -$22.3 million in 2025, then rose by 15.1% to -$18.9 million in 2026.
• Per Business Quant, the three latest ZURA Free Cash Flow figures stand at -$18.9 million (Q1 2026), -$22.3 million (Q4 2025), and -$15.5 million (Q3 2025).